European Healthtech startup funding raised during Q2 2019.
In Q2 2019, 38 European Healthtech companies raised a combined €1.0B across 38 funding rounds, up 17825.4% versus Q2 2018. UK led by capital raised, and Sofinnova Partners was the most active investor. Data as of 9 Jul 2026.
8 exits · €40M disclosed.
| EXIMO MEDICAL | Acquisition | Apr 2019 | €40M |
| €42M |
| iSTAR Medical | Series C | Jun 2019 | €40M |
| Microphyt | Other | Jun 2019 | €29M |
| Citryll | Series A | Jun 2019 | €15M |
| Ottonova | Growth/Late | May 2019 | €15M |
| Doktor | Other | Jun 2019 | €14M |
| GNA Biosolutions | Series C | Jun 2019 | €12M |
| AFYX Therapeutics | Other | Jun 2019 | €11M |
| PredictImmune | Series B | Jun 2019 | €11M |
| AblaCare | Series A | Jun 2019 | €10M |
| Osivax | Series A | Jun 2019 | €8.0M |
| Creoptix | Series C | Jun 2019 | €7.2M |
